Ocugen (OCGN) EPS (Basic) (QoQ) (2014 - 2025)
Ocugen (OCGN) EPS (Basic) (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -102.57% |
| Dec 31, 2023 | -465.15% |
| Sep 30, 2023 | 52.80% |
| Jun 30, 2023 | 4.48% |
| Mar 31, 2023 | 0.88% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | 19.53% |
| Jun 30, 2022 | 22.77% |
| Mar 31, 2022 | -117.81% |
| Dec 31, 2021 | -38.20% |
| Sep 30, 2021 | 59.23% |
| Jun 30, 2021 | 56.37% |
| Mar 31, 2021 | -800.58% |
| Dec 31, 2020 | 54.35% |
| Sep 30, 2020 | 61.76% |
| Jun 30, 2020 | -155.37% |
| Mar 31, 2020 | -108.50% |
| Dec 31, 2019 | 125.09% |
| Sep 30, 2019 | -158,187.50% |
| Jun 30, 2019 | 67.95% |